The interest rate of active bonds of 10-year and 30-year treasury bonds went down by more than 2bp, and the yield of main inter-bank interest bonds went down. The interest rate of 10-year treasury bonds went down by 2.15bp to 1.82%. The interest rate of 30-year national debt 2400006 fell by 2.15bp to 2.3075%; In 10 years, the interest rate of CDB 240215 dropped by 2.65bp to 1.886%.As of the close of early trading, the Nikkei 225 index fell by 0.65% and the Dongzheng index fell by 0.2%.Bank of America: restore coverage to AbbVie, give it a "neutral" rating, and target price is $191.
In response to the inclusion of the Spring Festival in the intangible cultural heritage of mankind, the Taiwan Affairs Office of the State Council held a regular press conference this morning. Zhu Fenglian, spokesperson of the Taiwan Affairs Office of the State Council, said that the Spring Festival is the most important traditional festival of the Chinese nation, an important moment to bid farewell to the old and welcome the new, and the most important cultural symbol in the hearts of Chinese children. Compatriots on both sides of the strait belong to the Chinese nation, descendants of the Chinese people and China people, and deeply understand that the Spring Festival contains the value pursuit of peace, harmony and harmony of the Chinese nation and Chinese civilization. In another 50 days, we will welcome the Spring Festival in year of the snake, the lunar calendar. We sincerely wish people on both sides of the strait to celebrate the Spring Festival together and carry forward the colorful Spring Festival culture together.The interest rate of active bonds of 10-year and 30-year treasury bonds went down by more than 2bp, and the yield of main inter-bank interest bonds went down. The interest rate of 10-year treasury bonds went down by 2.15bp to 1.82%. The interest rate of 30-year national debt 2400006 fell by 2.15bp to 2.3075%; In 10 years, the interest rate of CDB 240215 dropped by 2.65bp to 1.886%.The Hunan Provincial People's Procuratorate decided to arrest Lei Chunyong according to law. The case of Lei Chunyong (deputy department level), the former deputy secretary and vice chairman of the political consultative conference in Chenzhou City, Hunan Province, who was suspected of taking bribes and using his influence, was investigated by the Hunan Provincial Supervision Commission and transferred to the procuratorate for review and prosecution. A few days ago, the Hunan Provincial People's Procuratorate made an arrest decision on Lei Chunyong on suspicion of accepting bribes and using influence to accept bribes. The case is being further processed.
Kyle Rodda, a financial market analyst in Capital.com, looks forward to the US CPI in November: The expected CPI data basically gives the Fed a green light to cut interest rates next week, which may be the gold catalyst we need to see.Jizhi Co., Ltd.: Signed a supplementary agreement on development cooperation of 1.1 million yuan, and Jizhi Co., Ltd. announced that the company signed a supplementary agreement on entrusted development cooperation projects with Jiang Laboratory and Hangzhou Dilting Intelligent Technology Co., Ltd. According to the agreement, all parties have completed the development of intelligent underwater acoustic signal products, and will accelerate the application, promotion and industrialization of related products. The supplementary agreement stipulates that Jizhi shares will donate 1.1 million yuan to Zhejiang Zhijiang Development Foundation for public welfare. The signing of this agreement does not involve related party transactions, nor does it constitute a major asset restructuring. It still needs to be submitted to the company's second extraordinary shareholders meeting in 2024 for consideration. The signing of the agreement has limited impact on the company's short-term financial situation, but it is expected to have important strategic significance for the company's business development in the process of industrialization of related products.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.